Miro1 Impairment in a Parkinson’s At-Risk Cohort
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2021.734273
Abstract: There is a lack of reliable molecular markers for Parkinson’s disease (PD) patients and at-risk individuals. The detection of the pre-symptomatic population of PD will empower more effective clinical intervention to delay or prevent disease… read more here.
Keywords: risk; risk individuals; miro1 impairment; cohort ... See more keywords